MAINZ BIOMED B.V.

(MYNZ)
  Rapport
Temps Différé Nasdaq  -  21:58 24/06/2022
10.12 USD   +5.42%
21/06MAINZ BIOMED B.V. : HC Wainwright favorable sur le dossier
ZM
01/06Mainz Biomed B.V. Termine avec succès l'évaluation de conformité à l'Ivdr, atteignant ainsi un nouveau niveau de conformité à la réglementation européenne
CI
19/05Mainz Biomed et Dante Labs annoncent un partenariat pour la commercialisation de Coloalert en Europe et aux Émirats arabes unis (EAU)
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur MAINZ BIOMED B.V.
14/06MAINZ BIOMED B : ernennt Vizepräsidentin für klinische Angelegenheiten, um die klinischen ..
14/06Mainz Biomed Appoints Vice President of Clinical Affairs to Lead US Clinical Studies in..
14/06Mainz Biomed Appoints Vice President of Clinical Affairs to Lead US Clinical Studies in..
03/06MAINZ BIOMED B : ANNOUNCEMENT annual general meeting mainz biomed n.v - Form 6-K
01/06Mainz Biomed Successfully Completes Conformity Assessment to IVDR Achieving New Level o..
01/06Mainz Biomed Successfully Completes Conformity Assessment to IVDR Achieving New Level o..
01/06Mainz Biomed B.V. Successfully Completes Conformity Assessment to Ivdr Achieving New Le..
23/05MAINZ BIOMED B : kündigt Jahreshauptversammlung an
19/05Mainz Biomed Working With Dante Labs to Market Cancer Detection Test ColoAlert in Italy..
19/05Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert i..
19/05Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert i..
19/05Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of Coloalert i..
17/05Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity ..
17/05Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity ..
09/05Mainz Biomed to Host Key Opinion Leader Event at DDW 2022
09/05Mainz Biomed to Host Key Opinion Leader Event at DDW 2022
05/05Mainz Biomed Provides Product Development Update on PancAlert
05/05Mainz Biomed Provides Product Development Update on PancAlert
05/05Mainz Biomed Provides Product Development Update on Pancalert
03/05Certain Ordinary Shares of Mainz Biomed B.V. are subject to a Lock-Up Agreement Ending ..
26/04Mainz Biomed Names Darin Leigh as Chief Commercial Officer
26/04Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer
26/04Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer
12/04Mainz Biomed Announces First Quarter 2022 Results
31/03Mainz Biomed Receives 'Supportive Feedback' From FDA on Its Pre-Submission for Cancer D..
31/03Mainz Biomed Completes Successful Pre-Submission Process with the U.S FDA for ColoAlert..
31/03Mainz Biomed Completes Successful Pre-Submission Process with the U.S Fda for Coloalert..
21/03Mainz Biomed to Ring Nasdaq Stock Market Closing Bell
17/03Mainz Biomed Taps Sentinel Diagnostics, Alcedis for Support in Colorectal Cancer Trial
17/03Mainz Biomed Appoints Key Clinical Trial Partners for ColoFuture Study
09/03Mainz Biomed Announces Year End 2021 Results
02/03Mainz Biomed and Partners Join International Awareness Campaign for Colorectal Cancer A..
23/02MÄRKTE USA/Furcht vor russischer Invasion der Ukraine belastet Börsen
23/02Mainz Biomed Shares Rise 8% After Cancer Treatment Filing Approved By FDA
23/02SECTOR UPDATE : Health Care Stocks Gain During Premarket Wednesday
23/02Mainz Biomed Shares Rise Premarket After FDA to Review Cancer Test Kit
23/02Mainz Biomed Rises 13% as US FDA Accepts Pre-Submission for Colorectal Cancer Detection..
23/02Mainz Biomed Says FDA Has Accepted for Review Its Pre-Submission for Cancer Detection T..
23/02Mainz Biomed Provides U.S. Regulatory Review Update for ColoAlert
23/02Mainz Biomed Provides U.S. Regulatory Review Update for Coloalert
14/02Mainz Biomed Signs Commercialization Deal With Germany's Laboratory Monchengladbach for..
14/02Mainz Biomed Expands ColoAlert Commercialization with German Laboratory MVZ Dr. Stein +..
14/02Mainz Biomed Expands ColoAlert Commercialization with German Laboratory MVZ Dr. Stein +..
09/02Mainz Biomed Appoints Oncology Expert Dr. Rainer Metzger to Strategic Advisory Board
09/02Mainz Biomed B.V. Announces the Appointment of Dr. Rainer Metzger to Its Strategic Advi..
04/02Mainz Biomed Starts Study to Evaluate Integrating mRNA Biomarkers in Cancer Detection T..
04/02Mainz Biomed Initiates Clinical Study to Evaluate Integrating Novel mRNA Biomarkers Int..
04/02Mainz Biomed Initiates Clinical Study to Evaluate Integrating Novel mRNA Biomarkers Int..
28/01MAINZ BIOMED B : Announces Pricing of Follow-on Offering - Form 6-K
28/01NACHBÖRSE/XDAX +0,7% auf 15.432 Punkte
28/01Mainz Biomed Closes Common Stock Offering
28/01Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Co..
27/01Mainz Biomed Appoints Steve Quinn as VP Business Development
26/01Top Midday Decliners
26/01Top Premarket Decliners
26/01Mainz Biomed Prices Follow-on Offering at $15/Share, Expects $22.5 Million Gross Procee..
26/01Mainz Biomed Announces Pricing of Follow-on Offering
19/01Mainz Biomed Collaborating With DCN Dx in Clinical Study of Colorectal Cancer Testing T..
19/01Mainz Biomed Starts Collaboration with DCN Dx on Diagnostic Test Study
19/01Mainz Biomed Engages DCN Dx to Support Clinical Study Evaluating Novel mRNA Biomarkers ..
17/01Mainz Biomed setzen Rally mit Rekord fort
12/01Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business Deve..
12/01Mainz Biomed Appoints Michele Pedrocch to Strategic Advisory Board
11/01Mainz Biomed to Present at the H.C. Wainwright Bioconnect Virtual Conference
06/01MAINZ BIOMED B : Biomarkers Demonstrated Unique Ability to Identify Curable Precancerous C..
05/01MÄRKTE USA/Fed-Protokoll schickt Aktien auf Talfahrt - Zinsen steigen
05/01Health Care Stocks Down, Led by Biotechs
05/01Health Care Stocks Advancing Wednesday Afternoon
05/01Top Midday Gainers
05/01SECTOR UPDATE : Health Care
05/01MÄRKTE USA/Technikaktien weiter von Zinsanstieg gebremst
05/01MÄRKTE USA/Uneinheitlich - Nasdaq-Indizes hängen erneut zurück
05/01Wall Street Set for Narrow Losses Ahead of Fed Minutes
05/01Health Care Stocks Mixed Ahead of Wednesday's Open
05/01MÄRKTE USA/Abwartendes Geschäft vor Fed-Protokoll
1  2Suiv.